In this month’s PharmaTimes, Veeva’s life sciences compliance and data expert, Guillaume Roussel explains implications of the new EFPIA reporting requirements on public trust and marketing spend.
In this month’s PharmaTimes, Veeva’s life sciences compliance and data expert, Guillaume Roussel explains implications of the new EFPIA reporting requirements on public trust and marketing spend.